Press Releases

April 5, 2022
IN8bio to Present at April Investor and Scientific Conferences
PDF Version
March 28, 2022
IN8bio Presents Clinical Update from the Ongoing Phase 1 Trial of INB-100, an Allogeneic Gamma-Delta T Cell Therapy in Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant
PDF Version
March 17, 2022
IN8bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
PDF Version
March 4, 2022
IN8bio to present at March Investor and Scientific Conferences
PDF Version
February 10, 2022
IN8bio to present at Bio CEO & Investor Conference and Next Generation CAR-TCR Summit
PDF Version